Purchase Order 75N93021P01067

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order valued at $49,490 to Stemcell Technologies Inc., a Kent, Washington-based subsidiary of a Canadian biotechnology firm, on August 2, 2021. This contract represented an administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with an ultimate completion date of August 1, 2022. The award carried no small business set-aside designation and was issued without documented subcontractor involvement.

Stemcell Technologies Inc. is a specialized supplier of advanced biological research products and laboratory supplies, including cell isolation kits, cell culture media, cell separation systems, and research-grade reagents that support biomedical research across multiple scientific disciplines. The company maintains an extensive federal contracting presence, having received over 70 documented contract awards across numerous federal agencies including the National Institutes of Health institutes and centers, Centers for Disease Control and Prevention, Food and Drug Administration, and Department of Veterans Affairs. The vendor also holds a $10 million single-award Blanket Purchase Agreement with the National Institutes of Health Office of Logistics and Acquisition Operations, effective through December 31, 2026, which serves as a framework for procurement of biological materials and specialized research equipment across multiple NIH institutes and centers.